| US 7,544,685 B2 | ||
| 2,3-dihydroindole compounds | ||
| Benny Bang-Andersen, Copenhagen S (Denmark); Krestian Larsen, Ringsted (Denmark); and Niels Mørk, Virum (Denmark) | ||
| Assigned to H. Lundbeck A/S, Valby-Copenhagen (Denmark) | ||
| Filed on Aug. 15, 2006, as Appl. No. 11/504,186. | ||
| Claims priority of provisional application 60/709174, filed on Aug. 17, 2005. | ||
| Prior Publication US 2007/0043058 A1, Feb. 22, 2007 | ||
| Int. Cl. A61K 31/496 (2006.01); A61K 31/437 (2006.01); C07D 209/14 (2006.01); C07D 487/04 (2006.01); A61K 31/454 (2006.01); A61K 31/4439 (2006.01); C07D 401/0411 (2006.01) | ||
| U.S. Cl. 514—253.04 [514/254.09; 514/323; 514/339; 544/362; 544/373; 546/201; 546/278.1] | 24 Claims |
1. A compound of formula I
![]() wherein X—Y is N—CH2;
Z is CR10 or N;
R1 is A, A′ or A″
![]() wherein * indicates the atom attached to N via a bond;
R2 and R3 are independently selected from hydrogen and C1-6-alkyl;
R4-R7 are independently selected from hydrogen, C1-6-alkyl, C1-6-alkoxy and halogen;
R8 and R9 are independently selected from hydrogen and halogen;
R10 is hydrogen or halogen;
R11 and R12 are independently selected from hydrogen and C1-6-alkyl;
or enantiomers or pharmaceutically acceptable salts thereof.
|